3/5
07:41 am
imtx
Immatics Announces Full Year 2025 Financial Results and Business Update [Yahoo! Finance]
Low
Report
Immatics Announces Full Year 2025 Financial Results and Business Update [Yahoo! Finance]
3/5
07:00 am
imtx
Immatics Announces Full Year 2025 Financial Results and Business Update
Low
Report
Immatics Announces Full Year 2025 Financial Results and Business Update
3/1
01:10 am
imtx
Medium
Report
2/19
09:16 am
imtx
Immatics (NASDAQ:IMTX) was given a new $25.00 price target on by analysts at Mizuho.
Medium
Report
Immatics (NASDAQ:IMTX) was given a new $25.00 price target on by analysts at Mizuho.
1/24
05:08 am
imtx
Immatics (NASDAQ:IMTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Immatics (NASDAQ:IMTX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/15
08:31 am
imtx
Institutional investors own a significant stake of 38% in Immatics N.V. (NASDAQ:IMTX) [Yahoo! Finance]
Low
Report
Institutional investors own a significant stake of 38% in Immatics N.V. (NASDAQ:IMTX) [Yahoo! Finance]
1/11
01:03 am
imtx
Low
Report
1/3
01:06 am
imtx
Medium
Report
12/25
12:11 am
imtx
Immatics: PRAME Leader's Transition To Commercial Reality [Seeking Alpha]
Low
Report
Immatics: PRAME Leader's Transition To Commercial Reality [Seeking Alpha]
12/11
07:31 am
imtx
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress [Yahoo! Finance]
Low
Report
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress [Yahoo! Finance]
12/11
07:00 am
imtx
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
Low
Report
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
12/6
09:21 pm
imtx
Immatics (NasdaqCM:IMTX) Valuation Check After Follow-On Share Offering Announcement [Yahoo! Finance]
Low
Report
Immatics (NasdaqCM:IMTX) Valuation Check After Follow-On Share Offering Announcement [Yahoo! Finance]
12/5
06:24 am
imtx
Biotech Immatics to raise $125M through ordinary share offering [Seeking Alpha]
Medium
Report
Biotech Immatics to raise $125M through ordinary share offering [Seeking Alpha]
12/5
06:13 am
imtx
Immatics Announces $125 Million Underwritten Offering [Yahoo! Finance]
Medium
Report
Immatics Announces $125 Million Underwritten Offering [Yahoo! Finance]
12/5
06:00 am
imtx
Immatics Announces $125 Million Underwritten Offering
High
Report
Immatics Announces $125 Million Underwritten Offering